Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT04863508
Eligibility Criteria:
Inclusion Criteria:
* Willing to sign informed consent form
* Currently taking anti-hypertensive therapy for more than 3 months
* Drugs are unchanged during the study period
* Office BP below 140/90 mmHg at least one visit
Exclusion Criteria:
* Diagnosed with terminal illness
* End-stage renal disease requiring lifelong dialysis treatment
* Patients with impaired performance status (ECOG \>= 2)
* Women undergoing or expecting pregnancy during the study period
* Resistant hypertension (taking more than 4 kinds of anti-hypertensive drugs)
* Known atrial or ventricular arrhythmia
* Wrist circumference out-of range between 13.5 to 21.5 cm
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
85 Years
Study:
NCT04863508
Study Brief:
Protocol Section:
NCT04863508